IGFBP7 and colitis: In a mouse experimental colitis model, intraperitoneally injected MSCs ameliorated the clinical and histopathological severity of induced colonic inflammation and restored the injured gastrointestinal mucosal tissues, while MSCs that were knocked down for IGFBP7 had minimal effects (Liao et al., 2016).